Sudeep Pharma IPO Opens Today: Ready for another buzzworthy IPO on Dalal Street?
Sudeep Pharma Limited has officially opened its doors to investors, and if you’re eyeing this one, you’ve got time until 25 November 2025 to make your move.
The company has priced its shares between ₹563 and ₹593, and it’s aiming to scoop up ₹895 crore through a mix of fresh issue and OFS. Think of it as a neatly packed combo meal, ₹95 crore fresh shares and a hefty ₹800 crore served via the OFS route. The listing is set for both BSE and NSE, so it’s entering the big league with style.
Now, here’s the spicy bit: the grey market premium (GMP) is already humming at ₹130, hinting at early excitement. But hey, it’s the stock market, sentiments flip faster than a dosa!
Planning to apply or are you watching from the sidelines? Either way, the Sudeep Pharma IPO is one to keep on your radar.
Sudeep Pharma IPO- Quick Reference Table
| Category | Details |
|---|---|
| Price Band | ₹563 – ₹593 per equity share |
| IPO Open Date | 20 November 2025 |
| IPO Close Date | 25 November 2025 |
| Allotment Date | 26 November 2025 (expected) |
| Total Issue Size | ₹895 crore |
| Fresh Issue | ₹95 crore |
| Offer for Sale (OFS) | ₹800 crore |
| Lot Size | 25 shares per lot |
| Retail Application Rule | Must apply in multiples of 25 shares |
Sudeep Pharma IPO- Other Key IPO Essentials
-
Registrar:
MUFG Intime India has been appointed as the official registrar for the IPO. -
Lead Managers:
• ICICI Securities
• IIFL Capital Services
These firms are overseeing the book-building and issue management process. -
Listing Date:
The shares are expected to be listed on 28 November 2025.
Sudeep Pharma IPO- Grey Market Premium (GMP)
If you’re tracking Sudeep Pharma’s market buzz, here’s the number everyone’s whispering about, the IPO is commanding a ₹130 Grey Market Premium (GMP) as per early market observers. While GMP isn’t an official indicator, it does give a sneak peek into investor appetite before listing day. A premium of ₹130 suggests that sentiment around the IPO is comfortably positive, with buyers willing to pay above the upper price band even before the stock hits the exchanges. Still, seasoned investors know the drill: GMP can be tempting, but it’s no substitute for solid fundamentals and research.
(With Inputs)
Also Read: Stock Market Today: Muted Mood on Dalal Street as Sensex and Nifty Open Lower
Aishwarya is a journalism graduate with over three years of experience thriving in the buzzing corporate media world. She’s got a knack for decoding business news, tracking the twists and turns of the stock market, covering the masala of the entertainment world, and sometimes her stories come with just the right sprinkle of political commentary. She has worked with several organizations, interned at ZEE and gained professional skills at TV9 and News24, And now is learning and writing at NewsX, she’s no stranger to the newsroom hustle. Her storytelling style is fast-paced, creative, and perfectly tailored to connect with both the platform and its audience. Moto: Approaching every story from the reader’s point of view, backing up her insights with solid facts.
Always bold with her opinions, she also never misses the chance to weave in expert voices, keeping things balanced and insightful. In short, Aishwarya brings a fresh, sharp, and fact-driven voice to every story she touches.
